HPS Pharmacies wish to give notice that Aspen Pharmacare is experiencing a supply interruption for potassium chloride tablets as follows:
Normal supplies are expected to resume in October 2019. Aspen has reserved an extremely limited quantity of Span-K® stock for patients with an urgent clinical need. This supply will be allocated by Aspen on a case-by-case basis following completion of an application form by the prescribing physician. Alternatively, an internationally registered brand of potassium chloride 600mg sustained release tablets has been approved for supply under Section 19A of the Therapeutic Goods Act 1989.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Aspen Pharmacare on 1300 659 646.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates